Why Gilead Sciences' Successful COVID-19 Results Fell Flat

Why Gilead Sciences' Successful COVID-19 Results Fell Flat

A retrospective analysis said the still-experimental antiviral infusion significantly reduces COVID-19 patients' risk of death.